Catecholamine. Non-CYP metabolism. No data pointing to CYP-interaction.

Catecholamine.

Synthetic catecholamine used in intravenous short-duration treatment of chronic heart failure. Administered in infusion 1-6 ug/kg/minute in 0.9 %NaCl or 5% glucose solution.

Metabolized in the liver via O-methylation and O-sulfatation of the catechol hydroxyl group. Half time in blood 6-7 minutes.